Chemours Co (CC) SEC filings

CCNYSEChemicals & Allied ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$13.35−0.37 (-2.70%)

Close on Nov 12, 2026Market cap $2.01BP/E –Yield 3.84%

SEC filings

40 of Chemours's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Annual report, amended	10-K/A	Dec 31, 2025	Nov 3, 2026	SEC EDGAR
Current report	8-K	Nov 2, 2026	Nov 2, 2026	SEC EDGAR
Current report	8-K	Sep 9, 2026	Sep 10, 2026	SEC EDGAR
Current report	8-K	Sep 9, 2026	Sep 9, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 5, 2026	SEC EDGAR
Current report	8-K	Aug 4, 2026	Aug 4, 2026	SEC EDGAR
Current report	8-K	Jun 23, 2026	Jun 24, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 5, 2026	SEC EDGAR
Current report	8-K	May 5, 2026	May 5, 2026	SEC EDGAR
Current report	8-K	Apr 24, 2026	Apr 30, 2026	SEC EDGAR
Current report	8-K	Mar 12, 2026	Mar 12, 2026	SEC EDGAR
Proxy statement	DEF 14A	Apr 24, 2026	Mar 10, 2026	SEC EDGAR
Current report	8-K	Feb 26, 2026	Feb 26, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 24, 2026	SEC EDGAR
Current report	8-K	Feb 19, 2026	Feb 19, 2026	SEC EDGAR
Current report	8-K	Jan 15, 2026	Jan 16, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Oct 28, 2025	Oct 31, 2025	SEC EDGAR
Current report	8-K	Oct 13, 2025	Oct 16, 2025	SEC EDGAR
Current report	8-K	Sep 2, 2025	Sep 3, 2025	SEC EDGAR
Current report	8-K	Aug 29, 2025	Aug 29, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Aug 5, 2025	Aug 5, 2025	SEC EDGAR
Current report	8-K	Aug 3, 2025	Aug 4, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 6, 2025	SEC EDGAR
Current report	8-K	May 6, 2025	May 6, 2025	SEC EDGAR
Current report	8-K	Apr 22, 2025	Apr 24, 2025	SEC EDGAR
Current report	8-K	Mar 28, 2025	Mar 31, 2025	SEC EDGAR
Proxy statement	DEF 14A	Apr 22, 2025	Mar 20, 2025	SEC EDGAR
Current report	8-K	Mar 9, 2025	Mar 10, 2025	SEC EDGAR
Current report	8-K	Feb 13, 2025	Feb 18, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 18, 2025	SEC EDGAR
Current report	8-K	Feb 18, 2025	Feb 18, 2025	SEC EDGAR
Current report	8-K	Feb 10, 2025	Feb 11, 2025	SEC EDGAR
Current report	8-K	Jan 3, 2025	Jan 7, 2025	SEC EDGAR
Current report	8-K	Dec 13, 2024	Dec 13, 2024	SEC EDGAR
Current report	8-K	Nov 29, 2024	Nov 29, 2024	SEC EDGAR
Current report	8-K	Nov 27, 2024	Nov 27, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Chemours's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CC.

Compare: CC vs HUN · CC vs SOLS · CC vs OLN · CC vs IOSP · CC vs EMN

Revenue growth0.1% · median 0.6%

Gross margin15.2% · median 20.6%

Net margin-2.6% · median 1.9%

Company	Revenue	Growth
EMN	$9.05B	+0.3%
OLN	$6.74B	-0.7%
HUN	$5.90B	+0.6%
CC	$5.84B	+0.1%
SOLS	$4.17B	+9.4%
IOSP	$1.87B	+4.7%

Company

Next earnings (est.): Feb 18, 2027, after close
Exchange: NYSE
Industry: Chemicals & Allied Products
Fiscal year ends: December 31
Employees: 5,700
Held by institutions: 90.2%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1627223

Advertisement
300 × 250

See a number that looks wrong?